Compare CVS Health Corp (CVS) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs VanEck Junior Gold Miners — how do they compare? CVS Health Corp trades at $94.86 (market cap $119.58B), while VanEck Junior Gold Miners trades at $119.39. The key difference: CVS Health Corp pays a 2.84% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals.
| CVS | GDXJ | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $110.60 | $156.19 |
52-Week Low | $65.51 | $71.22 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $94.12, down 1.62% today, but maintains strong analyst support with 33 buy ratings and a $115.90 consensus price target. The company delivered three consecutive earnings beats in 2026, with Q2 EPS of $2.58 beating expectations by 38%. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, while fundamentals reveal solid revenue growth to $402.07B in 2025 despite margin compression.
CVS presents a compelling value opportunity with attractive valuation ratios (P/S: 0.29, P/B: 1.5) and strong institutional confidence. Near-term catalysts include continued Aetna recovery and healthcare services expansion, though risks include 2027 PBM pressures and margin volatility. The stock offers 23% upside to analyst targets with defensive healthcare positioning.
GDXJ, the VanEck Junior Gold Miners ETF, trades at $119.18, up 0.34% on the day, with a bullish technical signal driven by moving averages but tempered by overbought oscillators. Recent news highlights institutional selling and underperformance versus peers, while the ETF's composition shows less small-cap exposure than advertised. Key support lies at $118, with resistance at $120.
The outlook is mixed: bullish momentum persists near-term, but high RSI readings and negative sentiment from articles like Seeking Alpha (2026-06-24) suggest caution. Risks include gold price volatility and Federal Reserve policy shifts, while institutional activity, such as Amundi's 50.5% stake reduction (Defense World, 2026-08-06), indicates skepticism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
